Severe refractory hidradenitis suppurativa successfully treated with adalimumab in an HIV-positive/hepatitis C virus-positive patient

AIDS. 2018 Oct 23;32(16):2436-2438. doi: 10.1097/QAD.0000000000001998.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / administration & dosage*
  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Axilla / pathology
  • Female
  • HIV Infections / complications*
  • Hepatitis C, Chronic / complications*
  • Hidradenitis Suppurativa / drug therapy*
  • Humans
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Adalimumab